← Jazz Pharmaceuticals plc JAZZ
Market Price
$244.82
Market Cap
$15.41B
P/E Ratio
N/A
Revenue (FY 2025)
↑4.9% YoY
$4.27B
3-Yr CAGR: 5.3%
Net Income
↓-163.6% YoY
-$356.15M
Net Margin: -8.3%
Free Cash Flow
↓-4.5% YoY
$1.30B
FCF Yield: 8.42%
EPS (Diluted)
↓-167.5% YoY
$-5.84
Basic: $-5.84
Return on Equity
Efficiency
-8.2%
ROA: -8.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (JAZZ)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,488.0M | — | $1,094.5M | $396.8M | — | $6.41 | — | $590.5M | $582.7M | — |
| FY 2017 | $1,618.7M | +8.8% | $1,580.9M | $487.8M | +22.9% | $7.96 | +24.2% | $693.1M | $664.1M | +14.0% |
| FY 2018 | $1,890.9M | +16.8% | $1,834.2M | $447.1M | -8.4% | $7.30 | -8.3% | $798.9M | $778.5M | +17.2% |
| FY 2019 | $2,161.8M | +14.3% | $2,102.7M | $523.4M | +17.1% | $9.09 | +24.5% | $776.4M | $736.3M | -5.4% |
| FY 2020 | $2,363.6M | +9.3% | $2,287.5M | $238.6M | -54.4% | $4.22 | -53.6% | $899.6M | $884.6M | +20.2% |
| FY 2021 | $3,094.2M | +30.9% | $3,004.3M | $-329.7M | -238.2% | $-5.52 | -230.8% | $778.5M | $750.9M | -15.1% |
| FY 2022 | $3,659.4M | +18.3% | $3,626.6M | $-224.1M | +32.0% | $-3.58 | +35.1% | $1,272.0M | $1,242.9M | +65.5% |
| FY 2023 | $3,834.2M | +4.8% | $3,801.4M | $414.8M | +285.1% | $6.10 | +270.4% | $1,092.0M | $1,068.0M | -14.1% |
| FY 2024 | $4,068.9M | +6.1% | $2,101.9M | $560.1M | +35.0% | $8.65 | +41.8% | $1,395.9M | $1,357.8M | +27.1% |
| FY 2025 | $4,267.6M | +4.9% | $1,379.0M | $-356.1M | -163.6% | $-5.84 | -167.5% | $1,355.8M | $1,297.0M | -4.5% |
Valuation
Market Price
$244.82
Market Cap
$15.41B
Enterprise Value
$19.38B
P/E Ratio
N/A
P/B Ratio
3.56
FCF Yield
8.42%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
32.31%
Operating Margin
-10.08%
Net Margin
-8.35%
Return on Equity (ROE)
-8.25%
Return on Assets (ROA)
-8.55%
Asset Turnover
1.02x
Revenue 3-Yr CAGR
5.26%
Financial Health & Liquidity
Current Ratio
4.03
Cash Ratio
1.35
Debt / Equity
1.241
Debt / Assets
1.286
Cash & Equivalents
$1.39B
Total Debt
$5.36B
Book Value / Share
$68.83
Cash Flow Efficiency
Operating Cash Flow
$1.36B
Capital Expenditures (CapEx)
$58.75M
Free Cash Flow
$1.30B
OCF / Revenue
31.77%
FCF / Revenue
30.39%
FCF 3-Yr CAGR
1.43%
Per Share Metrics
EPS (Diluted)
$-5.84
EPS (Basic)
$-5.84
Dividends / Share
N/A
Book Value / Share
$68.83
EPS YoY Growth
-167.51%
Balance Sheet (FY 2025)
Total Assets
$4.17B
Total Liabilities
$1.03B
Stockholders' Equity
$4.32B
Current Assets
$4.17B
Current Liabilities
$1.03B